Bharat Biotech has said the firm expects approval for its vaccine Covaxin from the World Health Organisation (WHO) for Emergency Use Authorisation during July-September.
The company said regulatory approvals for Covid-9 vaccine Covaxin are in process in more than 60 countries including the USA, Brazil and Hungary among others.
"Application for EUL has been submitted to WHO-Geneva, regulatory approvals are expected July-September 2021," it said in a statement on Tuesday.
The bio tech firm said it has got EUA in 13 countries with more to follow.
Most countries recommend vaccinations against COVID-19.
"Application for EUL has been submitted to WHO-Geneva, regulatory approvals are expected July-September 2021," it said in a statement on Tuesday.Unvaccinated travelers can travel with negative RT-PCR tests prior to travel, in the absence of any other country specific travel restrictions, Bharat Biotech said.
Bharat Biotech receiving EUA for Covaxin from the WHO will be important as countries are preparing to gradually restart travel and tourism after prolonged COVID restrictions.
Travellers, especially students, are nervous about Covaxin still not being listed as an approved vaccine by the World Health Organisation and several countries.
The US, Canada, Australia, Ireland and the EU are among those that do not have Covaxin on their approved list of vaccines.
While Pfizer, Moderna and Covishield are in the approved list of the WHO, the organisation has asked Bharat Biotech to furnish "more information" to get emergency use listing (EUL) for its Covaxin vaccine for COVID-19.